{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-000995","form_type":"8-K","ticker":"GRCE","cik":"0001444192","company_name":"Grace Therapeutics, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.098687+00:00","generated_at":"2026-05-16T10:50:09.963026+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Grace Therapeutics amends severance for CEO (12-18 mo) and 4 execs (6 mo) as of Jan 10, 2026","bullets":["CEO Prashant Kohli gets 12 mo base salary (no CIC) or 18 mo base+target bonus (CIC) plus COBRA.","Four other executives get 6 mo base salary (no CIC) or 6 mo base+target bonus (CIC) plus COBRA.","Unvested equity forfeited on termination without Cause absent CIC; fully vests if terminated/resigned within 12 mo after CIC.","Amendments effective January 10, 2026; prior severance terms superseded."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-000995","json":"https://secwatch.observer/filing/0001140361-26-000995.json","markdown":"https://secwatch.observer/filing/0001140361-26-000995.md","text":"https://secwatch.observer/filing/0001140361-26-000995.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1444192/000114036126000995/0001140361-26-000995-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1444192/000114036126000995/ef20062691_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:50:09.963026+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}